Globus Medical (GMED) Research & Development (2011 - 2026)

Globus Medical's Research & Development history runs 16 years deep, the most recent figure standing at $36.5 million for Q1 2026.

• Quarterly Research & Development rose 10.43% year-over-year to $36.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.7 million (up 7.99% YoY) and the FY2025 annual result came in at $147.2 million, down 10.08% from the prior year.
• Research & Development was $36.5 million for Q1 2026 at Globus Medical, up from $36.2 million in the prior quarter.
• Across five years, Research & Development topped out at $52.3 million in Q4 2023 and bottomed at $12.6 million in Q1 2024.
• A 5-year average of $29.4 million and a median of $33.1 million in 2025 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development tumbled 61.77% — and 2023, when it surged 167.86%.
• Globus Medical's Research & Development stood at $19.5 million in 2022, then jumped by 167.86% to $52.3 million in 2023, then plunged by 36.06% to $33.4 million in 2024, then rose by 8.25% to $36.2 million in 2025, then increased by 0.96% to $36.5 million in 2026.
• Business Quant data shows GMED's Research & Development at $36.5 million in Q1 2026, $36.2 million in Q4 2025, and $38.1 million in Q3 2025.